These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 3196018)

  • 41. Rules and regulations for the production of allergenic extracts: past, present, future.
    Brede HD
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1985; (79):3-9. PubMed ID: 4051495
    [No Abstract]   [Full Text] [Related]  

  • 42. Regulatory control and standardization of allergenic extracts. Second International Paul-Ehrlich-Seminar Sept. 13th-15th, 1981.
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):1-278. PubMed ID: 6354088
    [No Abstract]   [Full Text] [Related]  

  • 43. Regulatory control and standardization of allergenic extracts. Third International Paul-Ehrlich-Seminar. September 18th-21st, 1983.
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1985; (79):1-352. PubMed ID: 4051492
    [No Abstract]   [Full Text] [Related]  

  • 44. Regulatory control and standardization of allergenic extracts. Progress and results following the resolutions of the First International Paul Ehrlich Seminar.
    Schaeffer M
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):3-6. PubMed ID: 6625584
    [No Abstract]   [Full Text] [Related]  

  • 45. Detection systems: the different principles for standardization of allergens.
    Løwenstein H
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1988; (82):113-6. PubMed ID: 3196013
    [No Abstract]   [Full Text] [Related]  

  • 46. [WHO position paper (summary)--allergen-immunotherapy: therapeutic vaccines for allergic diseases].
    Malling HJ
    Wien Med Wochenschr; 1999; 149(14-15):410-4. PubMed ID: 10584284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Food and Drug Administration reclassification of allergens for diagnosis and treatment: now is the time to be heard.
    Larenas-Linnemann DE; Finegold I; Nelson H
    Ann Allergy Asthma Immunol; 2012 Jul; 109(1):6-9. PubMed ID: 22727150
    [No Abstract]   [Full Text] [Related]  

  • 48. Standardization and efficacy of allergen extracts.
    Lichtenstein LM
    N Engl J Med; 1976 Nov; 295(21):1195-6. PubMed ID: 980024
    [No Abstract]   [Full Text] [Related]  

  • 49. Problems in allergen standardization.
    Platts-Mills TA; Rawle F; Chapman MD
    Clin Rev Allergy; 1985 Jul; 3(3):271-90. PubMed ID: 2410091
    [No Abstract]   [Full Text] [Related]  

  • 50. 2006 American Academy of Allergy, Asthma & Immunology member immunotherapy practice patterns and concerns.
    Coifman RE; Cox LS;
    J Allergy Clin Immunol; 2007 Apr; 119(4):1012-3. PubMed ID: 17418663
    [No Abstract]   [Full Text] [Related]  

  • 51. Allergenic extracts: a review of their safety and efficacy.
    Schaeffer M; Sisk LC
    Ann Allergy; 1984 Jan; 52(1):2-14. PubMed ID: 6364894
    [No Abstract]   [Full Text] [Related]  

  • 52. [Trends of international research work on immune toxicology and occupational allergy].
    Kusaka Y
    Sangyo Igaku; 1992 Dec; 34(7):663-6. PubMed ID: 1300386
    [No Abstract]   [Full Text] [Related]  

  • 53. Allergen immunotherapy: a new semantic framework from the European Academy of Allergy and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL consensus report.
    Calderón MA; Casale T; Cox L; Akdis CA; Burks AW; Nelson HS; Jutel M; Demoly P
    Allergy; 2013 Jul; 68(7):825-8. PubMed ID: 24010140
    [No Abstract]   [Full Text] [Related]  

  • 54. Regulatory control and standardization of allergenic extracts. Proceedings of the 9th International Paul-Ehrich-Seminar. September 9-11, 1999. Langen, Germany.
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1999; (93):1-304. PubMed ID: 11529201
    [No Abstract]   [Full Text] [Related]  

  • 55. Standardization and regulatory control of allergen extracts.
    Aas K
    Allergol Immunopathol (Madr); 1980; 8(3):197-202. PubMed ID: 7405766
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Allergens and allergen extracts].
    Havnen J
    Tidsskr Nor Laegeforen; 1973 Oct; 93(29):2151-3. PubMed ID: 4768384
    [No Abstract]   [Full Text] [Related]  

  • 57. [Purified house dust extracts or no house dust extract (author's transl)].
    Aas K
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1978; 73():145-47. PubMed ID: 756206
    [No Abstract]   [Full Text] [Related]  

  • 58. [Reactions during hyposensitizing therapy and their prevention].
    Belli E
    Folia Allergol (Roma); 1969; 16(4):440-1. PubMed ID: 5400589
    [No Abstract]   [Full Text] [Related]  

  • 59. Regulatory activities for allergenic extracts in the UK: the present situation.
    Ford A
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):29-35. PubMed ID: 6336595
    [No Abstract]   [Full Text] [Related]  

  • 60. Current standards and future directions in immunotherapy: perspectives on challenges and opportunities for the allergist.
    Bernstein DI; Blaiss MS; Cox LS; Finegold I; Lanier BQ; Nelson HS; Wallace DV
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):422-5. PubMed ID: 22018613
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.